Get started
Author

Clara Polizzi

Observed name: C. Polizzi
Observed institution: aTyr Pharma (United States)
ORCID: 0009-0003-0752-0260
Observed ORCID: 0009-0003-0752-0260
OpenAlex ID: A5060935963
Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer
2023 · Zhiwen Xu, Hira Lal Goel, et al. · Science Translational Medicine · 49
PDF
A human histidyl-tRNA synthetase splice variant therapeutic targets NRP2 to resolve lung inflammation and fibrosis
2025 · Leslie A. Nangle, Zhiwen Xu, et al. · Science Translational Medicine · 16
ATYR1923 Modulates the Inflammatory Response in Experimental Models of Interstitial Lung Disease
2019 · C. Burkart, M. Seikkula, et al. · American Journal of Respiratory and Critical Care Medicine · 5
Late Breaking Abstract - Immunomodulatory protein ATYR1923 disrupts an in vitro model of sarcoid granuloma formation
2021 · Suzanne Paz, Mark W. Julian, et al. · European Respiratory Journal · 4
Resolaris, a potential therapeutic for rare myopathies with an immune component
2015 · J. McKew, M. Ashlock, et al. · Neuromuscular Disorders · 2
Abstract LB095: A domain-specific antibody to NRP2 down-regulated epithelial-mesenchymal transition genes and enhanced efficacy of standard-of-care therapeutics for aggressive breast cancer
2021 · Zhiwen Xu, Christoph Burkart, et al. · Cancer Research · 1
Natural Asp-tRNA synthetase fragment targets myofibroblasts to abrogate tissue fibrosis
2026 · Ryan A. Adams, Ying-Ting Wang, et al. · Journal of Biological Chemistry
Abstract 4791: Immunosuppressive myeloid cells can be modulated with NRP2-targeting antibody ATYR2810 leading to enhanced anti-tumor immunity
2025 · Christoph Burkart, Clara Polizzi, et al. · Cancer Research
Abstract 1758: Resistance to cancer therapy via upregulation of the NRP2/VEGF-C axis can be neutralized by ATYR2810
2023 · Alison Barber, Zhiwen Xu, et al. · Cancer Research
Abstract LB085: ATYR2810, a fully humanized monoclonal antibody targeting the VEGF-NRP2 pathway sensitizes highly aggressive and chemoresistant TNBC subtypes to chemotherapy
2022 · Zhiwen Xu, Alison Barber, et al. · Cancer Research
Acute Experimental Pancreatitis in Rats Is Ameliorated by Treatment with Pramlintide, a Synthetic Analogue of the β-Cell Hormone Amylin
2007 · Bronislava Gedulin, Pamela Smith, et al. · The American Journal of Gastroenterology
Glucagon-Like Peptide-1 Combined with Captopril Provides Enhanced Benefits on Cardiac Function, Remodeling and Exercise Performance in Rats with Heart Failure
2006 · Que Liu, Anatoly Broyde, et al. · Journal of Cardiac Failure
Works count: 12
Citation count: 77
H-index: 4
I10-index: 2
Year
Topic
Type